These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 32992190)

  • 1. Dual Antiplatelet Therapy Beyond 90 days in Symptomatic Intracranial Stenosis in the SAMMPRIS Trial.
    Abdul Rahman L; Turan TN; Cotsonis G; Almallouhi E; Holmstedt CA; Chimowitz MI
    J Stroke Cerebrovasc Dis; 2020 Dec; 29(12):105254. PubMed ID: 32992190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial.
    Derdeyn CP; Chimowitz MI; Lynn MJ; Fiorella D; Turan TN; Janis LS; Montgomery J; Nizam A; Lane BF; Lutsep HL; Barnwell SL; Waters MF; Hoh BL; Hourihane JM; Levy EI; Alexandrov AV; Harrigan MR; Chiu D; Klucznik RP; Clark JM; McDougall CG; Johnson MD; Pride GL; Lynch JR; Zaidat OO; Rumboldt Z; Cloft HJ;
    Lancet; 2014 Jan; 383(9914):333-41. PubMed ID: 24168957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracranial stenosis: impact of randomized trials on treatment preferences of US neurologists and neurointerventionists.
    Turan TN; Cotsonis G; Lynn MJ; Wooley RH; Swanson S; Williams JE; Stern BJ; Derdeyn CP; Fiorella D; Chimowitz MI
    Cerebrovasc Dis; 2014; 37(3):203-11. PubMed ID: 24557055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Challenges in the Medical Management of Symptomatic Intracranial Stenosis in an Urban Setting.
    Sangha RS; Naidech AM; Corado C; Ansari SA; Prabhakaran S
    Stroke; 2017 Aug; 48(8):2158-2163. PubMed ID: 28679857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual Antiplatelet Therapy Using Cilostazol With Aspirin or Clopidogrel: Subanalysis of the CSPS.com Trial.
    Hoshino H; Toyoda K; Omae K; Ishida N; Uchiyama S; Kimura K; Sakai N; Okada Y; Tanaka K; Origasa H; Naritomi H; Houkin K; Yamaguchi K; Isobe M; Minematsu K; Matsumoto M; Tominaga T; Tomimoto H; Terayama Y; Yasuda S; Yamaguchi T;
    Stroke; 2021 Nov; 52(11):3430-3439. PubMed ID: 34404237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stenting versus aggressive medical therapy for intracranial arterial stenosis.
    Chimowitz MI; Lynn MJ; Derdeyn CP; Turan TN; Fiorella D; Lane BF; Janis LS; Lutsep HL; Barnwell SL; Waters MF; Hoh BL; Hourihane JM; Levy EI; Alexandrov AV; Harrigan MR; Chiu D; Klucznik RP; Clark JM; McDougall CG; Johnson MD; Pride GL; Torbey MT; Zaidat OO; Rumboldt Z; Cloft HJ;
    N Engl J Med; 2011 Sep; 365(11):993-1003. PubMed ID: 21899409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual antiplatelet therapy may increase the risk of non-intracranial haemorrhage in patients with minor strokes: a subgroup analysis of the CHANCE trial.
    Wang D; Gui L; Dong Y; Li H; Li S; Zheng H; Wang A; Meng X; Liu LP; Wang YL; Wang G; Jing J; Li Z; Zhao XQ; Wang YJ
    Stroke Vasc Neurol; 2016 Jun; 1(2):29-36. PubMed ID: 28959461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual Antiplatelet Therapy and Outcomes in Acute Mild to Moderate Stroke With Versus Without Large-Artery Atherosclerosis Post Hoc Analysis of ATAMIS.
    Cui Y; Liu QY; Chen HS
    J Am Heart Assoc; 2024 Sep; 13(18):e036318. PubMed ID: 39248249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does the Stenting Versus Aggressive Medical Therapy Trial Support Stenting for Subgroups With Intracranial Stenosis?
    Lutsep HL; Lynn MJ; Cotsonis GA; Derdeyn CP; Turan TN; Fiorella D; Janis LS; Lane BF; Montgomery J; Chimowitz MI;
    Stroke; 2015 Nov; 46(11):3282-4. PubMed ID: 26382173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of Early Bleeding with Dual Antiplatelet Therapy in Acute Stroke and Transient Ischemic Attack Regardless of NIHSS Admission.
    Scavasine VC; Barbosa RM; Lopes Neto FDN; Germininani FMB; Bazan R; Zétola VF; Massaro AR; Lange MC
    J Stroke Cerebrovasc Dis; 2021 May; 30(5):105677. PubMed ID: 33677312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness analysis of 30-month vs 12-month dual antiplatelet therapy with clopidogrel and aspirin after drug-eluting stents in patients with acute coronary syndrome.
    Jiang M; You JHS
    Clin Cardiol; 2017 Oct; 40(10):789-796. PubMed ID: 28683175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extended antiplatelet therapy with clopidogrel alone versus clopidogrel plus aspirin after completion of 9- to 12-month dual antiplatelet therapy for acute coronary syndrome patients with both high bleeding and ischemic risk. Rationale and design of the OPT-BIRISK double-blinded, placebo-controlled randomized trial.
    Li Y; Jing Q; Wang B; Wang X; Li J; Qiao S; Chen S; Angiolillo DJ; Han Y
    Am Heart J; 2020 Oct; 228():1-7. PubMed ID: 32739652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CYP2C19 Loss-of-Function is Associated with Increased Risk of Ischemic Stroke after Transient Ischemic Attack in Intracranial Atherosclerotic Disease.
    Patel PD; Vimalathas P; Niu X; Shannon CN; Denny JC; Peterson JF; Chitale RV; Fusco MR
    J Stroke Cerebrovasc Dis; 2021 Feb; 30(2):105464. PubMed ID: 33246208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 6- Versus 24-Month Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stents in Patients Nonresistant to Aspirin: Final Results of the ITALIC Trial (Is There a Life for DES After Discontinuation of Clopidogrel).
    Didier R; Morice MC; Barragan P; Noryani AAL; Noor HA; Majwal T; Hovasse T; Castellant P; Schneeberger M; Maillard L; Bressolette E; Wojcik J; Delarche N; Blanchard D; Jouve B; Ormezzano O; Paganelli F; Levy G; Sainsous J; Carrie D; Furber A; Berlan J; Darremont O; Le Breton H; Lyuycx-Bore A; Gommeaux A; Cassat C; Kermarrec A; Cazaux P; Druelles P; Dauphin R; Armengaud J; Dupouy P; Champagnac D; Ohlmann P; Ben Amer H; Kiss RG; Ungi I; Gilard M
    JACC Cardiovasc Interv; 2017 Jun; 10(12):1202-1210. PubMed ID: 28641840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CYP2C19 and CES1 polymorphisms and efficacy of clopidogrel and aspirin dual antiplatelet therapy in patients with symptomatic intracranial atherosclerotic disease.
    Hoh BL; Gong Y; McDonough CW; Waters MF; Royster AJ; Sheehan TO; Burkley B; Langaee TY; Mocco J; Zuckerman SL; Mummareddy N; Stephens ML; Ingram C; Shaffer CM; Denny JC; Brilliant MH; Kitchner TE; Linneman JG; Roden DM; Johnson JA
    J Neurosurg; 2016 Jun; 124(6):1746-51. PubMed ID: 26587656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aspirin Versus Aspirin Plus Clopidogrel as Antithrombotic Treatment Following Transcatheter Aortic Valve Replacement With a Balloon-Expandable Valve: The ARTE (Aspirin Versus Aspirin + Clopidogrel Following Transcatheter Aortic Valve Implantation) Randomized Clinical Trial.
    Rodés-Cabau J; Masson JB; Welsh RC; Garcia Del Blanco B; Pelletier M; Webb JG; Al-Qoofi F; Généreux P; Maluenda G; Thoenes M; Paradis JM; Chamandi C; Serra V; Dumont E; Côté M
    JACC Cardiovasc Interv; 2017 Jul; 10(13):1357-1365. PubMed ID: 28527771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors associated with 90-day recurrent stroke in patients on dual antiplatelet therapy for minor stroke or high-risk TIA: a subgroup analysis of the CHANCE trial.
    Wangqin R; Wang X; Wang Y; Xian Y; Zhao X; Liu L; Li H; Meng X; Wang Y
    Stroke Vasc Neurol; 2017 Dec; 2(4):176-183. PubMed ID: 29507777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clopidogrel and aspirin after ischemic stroke or transient ischemic attack: an updated systematic review and meta-analysis of randomized clinical trials.
    Kheiri B; Osman M; Abdalla A; Haykal T; Swaid B; Ahmed S; Chahine A; Hassan M; Bachuwa G; Al Qasmi M; Bhatt DL
    J Thromb Thrombolysis; 2019 Feb; 47(2):233-247. PubMed ID: 30511260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One year clinical outcome of dual anti-platelet therapy with the Novel Ticagrelor plus Aspirin versus Clopidogrel plus Aspirin for Endovascular Intervention of patients with Intracranial Aneurysm: A meta-analysis.
    Zhou Y; He S; Hu Y
    J Stroke Cerebrovasc Dis; 2024 Jan; 33(1):107491. PubMed ID: 37988833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome in patients previously on antithrombotic therapy in the SAMMPRIS trial: subgroup analysis.
    Lutsep HL; Barnwell SL; Larsen DT; Lynn MJ; Hong M; Turan TN; Derdeyn CP; Fiorella D; Janis LS; Chimowitz MI;
    Stroke; 2015 Mar; 46(3):775-9. PubMed ID: 25593135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.